 | Up a level |
Golfmann, K., Meder, L., Schuldt, P. and Ullrich, R. (2016). The role of FGFR1 signaling in breast cancer to induce tumor angiogenesis. Oncol. Res. Treat., 39. S. 118 - 119. BASEL: KARGER. ISSN 2296-5262
Meder, L., Schuldt, P., Thelen, M., Dietlein, F., von Baildon, Bergwelt M., Reinhardt, C. and Ullrich, R. T. (2017). Dual inhibition of anti-VEGF and anti-PD-L1 displays synergistic treatment effects in a small cell lung carcinoma mouse model. Oncol. Res. Treat., 40. S. 175 - 176. BASEL: KARGER. ISSN 2296-5262
Meder, L., Schuldt, P., Vlasic, I, Volz, C., Golfmann, K., Zaplatina, A., Florin, A., Tharun, L., Buettner, R., Reinhardt, C. and Ullrich, R. (2016). Combining anti-VEGF therapy and immune checkpoint inhibitors improves outcome in small cell lung carcinomas. Oncol. Res. Treat., 39. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262